ATLI, E.; KALKAN, R.; MAIL, C. .; EKER, D. .; DEMIRCI, U.; DEMIR, S. .; YALCINTEPE, S.; KIRKIZLAR, H. O. .; ATLI, E. .; GURKAN, H.; DEMIR, A. M. . THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES: Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 13, n. 1, p. e2021013, 2021. DOI: 10.4084/mjhid.2021.013. Disponível em: Acesso em: 22 oct. 2021.